TREVIAMET (Sitagliptin+ Metformin HCl) is indicated as: - Initial therapy in patient
TREVIAMET (Sitagliptin+ Metformin HCl) is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control.
Related products